Inhibition of thromboxane A2 synthesis by OKY-046 attenuates ischemia and reperfusion injury of the liver

Transplant Proc. 1999 Feb-Mar;31(1-2):1061-2. doi: 10.1016/s0041-1345(98)01904-6.
No abstract available

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / blood
  • Alanine Transaminase / blood
  • Animals
  • Blood Pressure / drug effects
  • Dogs
  • Enzyme Inhibitors / pharmacology
  • Female
  • Ischemia / physiopathology
  • Liver / blood supply*
  • Liver Circulation / drug effects*
  • Methacrylates / pharmacology*
  • Portal Vein / drug effects
  • Portal Vein / physiology
  • Portal Vein / physiopathology
  • Regional Blood Flow / drug effects
  • Reperfusion Injury / prevention & control*
  • Thromboxane A2 / blood
  • Thromboxane-A Synthase / antagonists & inhibitors*

Substances

  • Enzyme Inhibitors
  • Methacrylates
  • Thromboxane A2
  • 6-Ketoprostaglandin F1 alpha
  • Alanine Transaminase
  • Thromboxane-A Synthase
  • ozagrel